Did you know chronic headaches affect 1.89 billion people worldwide?

Yet, despite this staggering number, treatment options remain limited. In our efforts to explore the therapeutic potential of microdosing psychedelics, we've launched our first ever research study surveying the effects of psychedelics like psilocybin and LSD for headache relief.

Study Details:

✅ Participant Requirements:

• 18 years of age or older

• Have chronic headaches (15+ per month for at least 3 months)

• Have used psychedelics while experiencing these headaches (at any dose)

• Reside in North America (except for Quebec)

🔬 Research Study Details:

• 100% online research survey

• Completely anonymous, HIPAA & PHIPA compliant

• Takes approximately 15-20 minutes

• Deadline: Enrollment closes on June 20, 2025.

Led by our Research Director, Stephanie Karzon, MSc, and our Medical Advisor, Dr. Evan Lewis, this study seeks to gather real experiences and feedback from the community.

By contributing to this research, whether through sharing it with your network or completing it yourself, you’ll help advance the science behind psychedelics and their legalization. 🙌 

Have questions? 
Reply to this email, and we'll get back to you.

- With love from team Microdosing Collective 🍄

Was this email forwarded? Subscribe to get the next one delivered right to you!

DISCLAIMER: This newsletter is intended for educational and informational purposes only and should not be considered a replacement for professional medical advice. Always consult your healthcare provider before making changes. Please be aware that the use, possession, and distribution of psychedelic substances are illegal in many countries and could lead to legal consequences.